Tag: ClinicalStudy

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Kintara Therapeutics (NASDAQ: KTRA) Fast Track Designation from FDA for REM-001

financial buzz11/28/202211/28/2022

16821

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Kintara Therapeutics Granted Fast Track Designation from FDA for REM-001” Kintara Therapeutics, Inc. (NASDAQ: KTRA) (“Kintara” or the...

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

VistaGen Reports Topline Results from PALISADE-1 Phase 3 Clinical Trial for PH94B

Andy Liao07/22/2022

20068

VistaGen Therapeutics, Inc. (NASDAQ: VTGN) announced topline results from its PALISADE-1 Phase 3 clinical trial of PH94B for the treatment of anxiety in adults with social anxiety disorder. PH94B...

Tag: ClinicalStudy

“The Buzz” Show: Kintara Therapeutics (NASDAQ: KTRA) Fast Track Designation from FDA for REM-001

VistaGen Reports Topline Results from PALISADE-1 Phase 3 Clinical Trial for PH94B

ABOUT US

Tweets